Windlas Biotech will host an earnings call on May 22, 2026, to discuss Q4 and FY26 financial results.
Management participants include MD Hitesh Windlass and CEO & CFO Komal Gupta for the discussion.
The call is scheduled post-results and complies with SEBI LODR Regulation 30 disclosure requirements.
Dial-in details and a Diamond Pass link are provided for investor access to the conference.